Weight loss, changes in body composition and inflammatory status after a very low-energy ketogenic therapy (VLEKT): does gender matter?
Body composition
Gender
Ketogenic diet
Nutrition
Obesity
Sex
VLCKD
Very Low-Energy Ketogenic Therapy (VLEKT)
Very low-calorie ketogenic diet
Weight loss
Journal
Journal of translational medicine
ISSN: 1479-5876
Titre abrégé: J Transl Med
Pays: England
ID NLM: 101190741
Informations de publication
Date de publication:
19 Oct 2024
19 Oct 2024
Historique:
received:
16
06
2024
accepted:
06
10
2024
medline:
20
10
2024
pubmed:
20
10
2024
entrez:
19
10
2024
Statut:
epublish
Résumé
Considering differences in body composition and inflammatory status between sexes, as well as recent recommendations advocating for personalized dietary approaches, this study aimed to explore how sex influences weight loss, changes in body composition, and inflammatory status in subjects with grade I and II obesity undergoing a 45-day of the Very Low-Energy Ketogenic Therapy (VLEKT). Participants (21 premenopausal females and 21 males), included in the study adhered to the 45-day of the VLEKT and underwent assessments of anthropometric parameters (weight, height, body mass index-BMI -, and waist circumference), body composition via bioelectrical impedance analysis, and inflammatory status measured by high sensitivity C-reactive protein (hs-CRP) levels at baseline and post-intervention. At baseline, premenopausal females and males did not differ in BMI (p = 0.100) and hs-CRP levels (p = 0.948). Males demonstrated overall larger benefits than premenopausal females from the VLEKT in terms of weight loss (Δ% = - 11.63 ± 1.76 vs - 8.95 ± 1.65 kg, p < 0.001), fat mass (Δ% = - 30.84 ± 12.00 vs -21.36 ± 4.65 kg, p = 0.002), and hs-CRP levels (Δ% = - 41.42 ± 21.35 vs - 22.38 ± 17.30 mg/L, p = 0.003). Of interest, in males phase angle values are statistically improved compared to female (Δ% = 17.11 ± 9.00 vs 7.05 ± 3.30°, p < 0.001). These findings underscore the importance of considering sex-specific responses in personalized obesity treatment strategies, particularly dietary interventions like VLEKTs.
Sections du résumé
BACKGROUND
BACKGROUND
Considering differences in body composition and inflammatory status between sexes, as well as recent recommendations advocating for personalized dietary approaches, this study aimed to explore how sex influences weight loss, changes in body composition, and inflammatory status in subjects with grade I and II obesity undergoing a 45-day of the Very Low-Energy Ketogenic Therapy (VLEKT).
METHODS
METHODS
Participants (21 premenopausal females and 21 males), included in the study adhered to the 45-day of the VLEKT and underwent assessments of anthropometric parameters (weight, height, body mass index-BMI -, and waist circumference), body composition via bioelectrical impedance analysis, and inflammatory status measured by high sensitivity C-reactive protein (hs-CRP) levels at baseline and post-intervention.
RESULTS
RESULTS
At baseline, premenopausal females and males did not differ in BMI (p = 0.100) and hs-CRP levels (p = 0.948). Males demonstrated overall larger benefits than premenopausal females from the VLEKT in terms of weight loss (Δ% = - 11.63 ± 1.76 vs - 8.95 ± 1.65 kg, p < 0.001), fat mass (Δ% = - 30.84 ± 12.00 vs -21.36 ± 4.65 kg, p = 0.002), and hs-CRP levels (Δ% = - 41.42 ± 21.35 vs - 22.38 ± 17.30 mg/L, p = 0.003). Of interest, in males phase angle values are statistically improved compared to female (Δ% = 17.11 ± 9.00 vs 7.05 ± 3.30°, p < 0.001).
CONCLUSION
CONCLUSIONS
These findings underscore the importance of considering sex-specific responses in personalized obesity treatment strategies, particularly dietary interventions like VLEKTs.
Identifiants
pubmed: 39427162
doi: 10.1186/s12967-024-05733-3
pii: 10.1186/s12967-024-05733-3
doi:
Substances chimiques
C-Reactive Protein
9007-41-4
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
949Informations de copyright
© 2024. The Author(s).
Références
Organization WH. The programme for gender equality, human rights & health equity. 2024; https://www.who.int/teams/gender-equity-and-human-rights .
Mauvais-Jarvis F, Bairey Merz N, Barnes PJ, et al. Sex and gender: modifiers of health, disease, and medicine. Lancet. 2020;396(10250):565–82. https://doi.org/10.1016/S0140-6736(20)31561-0 .
doi: 10.1016/S0140-6736(20)31561-0
pubmed: 32828189
pmcid: 7440877
Cooper AJ, Gupta SR, Moustafa AF, Chao AM. Sex/gender differences in obesity prevalence, comorbidities, and treatment. Curr Obes Rep. 2021;10(4):458–66. https://doi.org/10.1007/s13679-021-00453-x .
doi: 10.1007/s13679-021-00453-x
pubmed: 34599745
Barrea L, Verde L, Suarez R, et al. Sex-differences in Mediterranean diet: a key piece to explain sex-related cardiovascular risk in obesity? A cross-sectional study. J Transl Med. 2024;22(1):44. https://doi.org/10.1186/s12967-023-04814-z .
doi: 10.1186/s12967-023-04814-z
pubmed: 38200498
pmcid: 10782790
Organization WH. Obesity and overweight. 2023; https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight .
Martin M, Beekley A, Kjorstad R, Sebesta J. Socioeconomic disparities in eligibility and access to bariatric surgery: a national population-based analysis. Surg Obes Relat Dis. 2010;6(1):8–15. https://doi.org/10.1016/j.soard.2009.07.003 .
doi: 10.1016/j.soard.2009.07.003
pubmed: 19782647
Muscogiuri G, Verde L, Vetrani C, Barrea L, Savastano S, Colao A. Obesity: a gender-view. J Endocrinol Invest. 2023. https://doi.org/10.1007/s40618-023-02196-z .
doi: 10.1007/s40618-023-02196-z
pubmed: 37740888
pmcid: 10859324
Gerdts E, Regitz-Zagrosek V. Sex differences in cardiometabolic disorders. Nat Med. 2019;25(11):1657–66. https://doi.org/10.1038/s41591-019-0643-8 .
doi: 10.1038/s41591-019-0643-8
pubmed: 31700185
Imhof A, Frohlich M, Loewel H, et al. Distributions of C-reactive protein measured by high-sensitivity assays in apparently healthy men and women from different populations in Europe. Clin Chem. 2003;49(4):669–72. https://doi.org/10.1373/49.4.669 .
doi: 10.1373/49.4.669
pubmed: 12651827
Khera A, McGuire DK, Murphy SA, et al. Race and gender differences in C-reactive protein levels. J Am Coll Cardiol. 2005;46(3):464–9. https://doi.org/10.1016/j.jacc.2005.04.051 .
doi: 10.1016/j.jacc.2005.04.051
pubmed: 16053959
Lakoski SG, Cushman M, Criqui M, et al. Gender and C-reactive protein: data from the multiethnic study of atherosclerosis (MESA) cohort. Am Heart J. 2006;152(3):593–8. https://doi.org/10.1016/j.ahj.2006.02.015 .
doi: 10.1016/j.ahj.2006.02.015
pubmed: 16923436
Williams RL, Wood LG, Collins CE, Callister R. Effectiveness of weight loss interventions–is there a difference between men and women: a systematic review. Obes Rev. 2015;16(2):171–86. https://doi.org/10.1111/obr.12241 .
doi: 10.1111/obr.12241
pubmed: 25494712
Robertson C, Avenell A, Boachie C, et al. Should weight loss and maintenance programmes be designed differently for men? A systematic review of long-term randomised controlled trials presenting data for men and women: the ROMEO project. Obes Res Clin Pract. 2016;10(1):70–84. https://doi.org/10.1016/j.orcp.2015.04.005 .
doi: 10.1016/j.orcp.2015.04.005
pubmed: 25937165
Barrea L, Verde L, Camajani E, et al. Effects of very low-calorie ketogenic diet on hypothalamic-pituitary-adrenal axis and renin-angiotensin-aldosterone system. J Endocrinol Invest. 2023;46(8):1509–20. https://doi.org/10.1007/s40618-023-02068-6 .
doi: 10.1007/s40618-023-02068-6
pubmed: 37017918
pmcid: 10349006
Barrea L, Verde L, Di Lorenzo C, Savastano S, Colao A, Muscogiuri G. Can the ketogenic diet improve our dreams? Effect of very low-calorie ketogenic diet (VLCKD) on sleep quality. J Transl Med. 2023;21(1):479. https://doi.org/10.1186/s12967-023-04280-7 .
doi: 10.1186/s12967-023-04280-7
pubmed: 37464397
pmcid: 10353204
Barrea L, Verde L, Santangeli P, et al. Very low-calorie ketogenic diet (VLCKD): an antihypertensive nutritional approach. J Transl Med. 2023;21(1):128. https://doi.org/10.1186/s12967-023-03956-4 .
doi: 10.1186/s12967-023-03956-4
pubmed: 36800966
pmcid: 9936635
Camajani E, Feraco A, Verde L, et al. Ketogenic diet as a possible non-pharmacological therapy in main endocrine diseases of the female reproductive system: a practical guide for nutritionists. Curr Obes Rep. 2023;12(3):231–49. https://doi.org/10.1007/s13679-023-00516-1 .
doi: 10.1007/s13679-023-00516-1
pubmed: 37405618
pmcid: 10482777
Camajani E, Feraco A, Proietti S, et al. Very low calorie ketogenic diet combined with physical interval training for preserving muscle mass during weight loss in sarcopenic obesity: a pilot study. Front Nutr. 2022;9: 955024. https://doi.org/10.3389/fnut.2022.955024 .
doi: 10.3389/fnut.2022.955024
pubmed: 36245515
pmcid: 9560671
Muscogiuri G, El Ghoch M, Colao A, et al. European guidelines for obesity management in adults with a very low-calorie ketogenic diet: a systematic review and meta-analysis. Obes Facts. 2021;14(2):222–45. https://doi.org/10.1159/000515381 .
doi: 10.1159/000515381
pubmed: 33882506
pmcid: 8138199
Barrea L, Caprio M, Camajani E, et al. Ketogenic nutritional therapy (KeNuT)-a multi-step dietary model with meal replacements for the management of obesity and its related metabolic disorders: a consensus statement from the working group of the Club of the Italian Society of Endocrinology (SIE)-diet therapies in endocrinology and metabolism. J Endocrinol Invest. 2024. https://doi.org/10.1007/s40618-023-02258-2 .
doi: 10.1007/s40618-023-02258-2
pubmed: 39292364
pmcid: 10904420
Barrea L, Verde L, Schiavo L, et al. Very Low-Calorie Ketogenic Diet (VLCKD) as Pre-Operative First-Line Dietary Therapy in Patients with Obesity Who Are Candidates for Bariatric Surgery. Nutrients. 2023;15(8). https://doi.org/10.3390/nu15081907 .
Barrea L, Caprio M, Grassi D, et al. A new nomenclature for the very low-calorie ketogenic diet (VLCKD): very low-energy ketogenic therapy (VLEKT). Ketodiets and nutraceuticals expert panels: “KetoNut”, Italian Society of Nutraceuticals (SINut) and the Italian Association of Dietetics and Clinical Nutrition (ADI). Curr Nutr Rep. 2024;13(3):552–6. https://doi.org/10.1007/s13668-024-00560-w .
doi: 10.1007/s13668-024-00560-w
pubmed: 39039372
pmcid: 11327192
D’Abbondanza M, Ministrini S, Pucci G, et al. Very low-carbohydrate ketogenic diet for the treatment of severe obesity and associated non-alcoholic fatty liver disease: the role of sex differences. Nutrients. 2020. https://doi.org/10.3390/nu12092748 .
doi: 10.3390/nu12092748
pubmed: 32916989
pmcid: 7551320
Rinaldi R, De Nucci S, Donghia R, et al. Gender differences in liver steatosis and fibrosis in overweight and obese patients with metabolic dysfunction-associated steatotic liver disease before and after 8 weeks of very low-calorie ketogenic diet. Nutrients. 2024. https://doi.org/10.3390/nu16101408 .
doi: 10.3390/nu16101408
pubmed: 38999827
pmcid: 11243313
Barrea L, Verde L, Simancas-Racines D, et al. Adherence to the Mediterranean diet as a possible additional tool to be used for screening the metabolically unhealthy obesity (MUO) phenotype. J Transl Med. 2023;21(1):675. https://doi.org/10.1186/s12967-023-04546-0 .
doi: 10.1186/s12967-023-04546-0
pubmed: 37770999
pmcid: 10540328
Barrea L, Verde L, Vetrani C, Savastano S, Colao A, Muscogiuri G. Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? Nutrients. 2022. https://doi.org/10.3390/nu14050955 .
doi: 10.3390/nu14050955
pubmed: 36235866
pmcid: 9571084
Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894:i-xii, 1–253.
Prevention CfDCa. National health and nutrition examination survey: anthropometry procedures manual. 2007; https://www.cdc.gov/nchs/data/nhanes/nhanes_07_08/manual_an.pdf .
Kyle UG, Bosaeus I, De Lorenzo AD, et al. Bioelectrical impedance analysis-part II: utilization in clinical practice. Clin Nutr. 2004;23(6):1430–53. https://doi.org/10.1016/j.clnu.2004.09.012 .
doi: 10.1016/j.clnu.2004.09.012
pubmed: 15556267
Barrea L, Muscogiuri G, Laudisio D, et al. Phase angle: a possible biomarker to quantify inflammation in subjects with Obesity and 25(OH)D deficiency. Nutrients. 2019. https://doi.org/10.3390/nu11081747 .
doi: 10.3390/nu11081747
pubmed: 31842281
pmcid: 6950363
Bera TK. Bioelectrical impedance methods for noninvasive health monitoring: a review. J Med Eng. 2014;2014: 381251. https://doi.org/10.1155/2014/381251 .
doi: 10.1155/2014/381251
pubmed: 27006932
pmcid: 4782691
Kumar S, Dutt A, Hemraj S, Bhat S, Manipadybhima B. Phase angle measurement in healthy human subjects through bio-impedance analysis. Iran J Basic Med Sci. 2012;15(6):1180–4.
pubmed: 23653848
pmcid: 3646229
Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association. Circulation. 2003;107(3):499–511. https://doi.org/10.1161/01.cir.0000052939.59093.45 .
doi: 10.1161/01.cir.0000052939.59093.45
pubmed: 12551878
Flegal KM, Kruszon-Moran D, Carroll MD, Fryar CD, Ogden CL. Trends in obesity among adults in the United States, 2005 to 2014. JAMA. 2016;315(21):2284–91. https://doi.org/10.1001/jama.2016.6458 .
doi: 10.1001/jama.2016.6458
pubmed: 27272580
pmcid: 11197437
2015 IOoHR. Health status and quality of care in the Italian regions. In:2015.
Chang E, Varghese M, Singer K. Gender and sex differences in adipose tissue. Curr Diab Rep. 2018;18(9):69. https://doi.org/10.1007/s11892-018-1031-3 .
doi: 10.1007/s11892-018-1031-3
pubmed: 30058013
pmcid: 6525964
Biasioli S, Foroni R, Petrosino L, et al. Effect of aging on the body composition of dialyzed subjects. Comp Normal Sub ASAIO J. 1993;39(3):M596-601.
Chumlea WC, Guo SS, Cockram DB, Siervogel RM. Mechanical and physiologic modifiers and bioelectrical impedance spectrum determinants of body composition. Am J Clin Nutr. 1996;64(3 Suppl):413S-422S. https://doi.org/10.1093/ajcn/64.3.413S .
doi: 10.1093/ajcn/64.3.413S
pubmed: 8780357
Denti L, Pasolini G, Sanfelici L, et al. Effects of aging on dehydroepiandrosterone sulfate in relation to fasting insulin levels and body composition assessed by bioimpedance analysis. Metabolism. 1997;46(7):826–32. https://doi.org/10.1016/s0026-0495(97)90130-x .
doi: 10.1016/s0026-0495(97)90130-x
pubmed: 9225839
Mattar JA. Application of total body bioimpedance to the critically ill patient. Brazilian Group for Bioimpedance Study. New Horiz. 1996;4(4):493–503.
pubmed: 8968982
Zdolsek HJ, Lindahl OA, Sjoberg F. Non-invasive assessment of fluid volume status in the interstitium after haemodialysis. Physiol Meas. 2000;21(2):211–20. https://doi.org/10.1088/0967-3334/21/2/301 .
doi: 10.1088/0967-3334/21/2/301
pubmed: 10847188
Stobaus N, Pirlich M, Valentini L, Schulzke JD, Norman K. Determinants of bioelectrical phase angle in disease. Br J Nutr. 2012;107(8):1217–20. https://doi.org/10.1017/S0007114511004028 .
doi: 10.1017/S0007114511004028
pubmed: 22309898
Dittmar M. Reliability and variability of bioimpedance measures in normal adults: effects of age, gender, and body mass. Am J Phys Anthropol. 2003;122(4):361–70. https://doi.org/10.1002/ajpa.10301 .
doi: 10.1002/ajpa.10301
pubmed: 14614757
Ritz P, Vol S, Berrut G, Tack I, Arnaud MJ, Tichet J. Influence of gender and body composition on hydration and body water spaces. Clin Nutr. 2008;27(5):740–6. https://doi.org/10.1016/j.clnu.2008.07.010 .
doi: 10.1016/j.clnu.2008.07.010
pubmed: 18774628
DiGirolamo M, Owens JL. Water content of rat adipose tissue and isolated adipocytes in relation to cell size. Am J Physiol. 1976;231(5 Pt. 1):1568–72. https://doi.org/10.1152/ajplegacy.1976.231.5.1568 .
doi: 10.1152/ajplegacy.1976.231.5.1568
pubmed: 998803
Wang J, Pierson RN Jr. Disparate hydration of adipose and lean tissue require a new model for body water distribution in man. J Nutr. 1976;106(12):1687–93. https://doi.org/10.1093/jn/106.12.1687 .
doi: 10.1093/jn/106.12.1687
pubmed: 993849
Waki M, Kral JG, Mazariegos M, Wang J, Pierson RN Jr, Heymsfield SB. Relative expansion of extracellular fluid in obese vs. nonobese women. Am J Physiol. 1991;261(2 Pt 1):199–203. https://doi.org/10.1152/ajpendo.1991.261.2.E199 .
doi: 10.1152/ajpendo.1991.261.2.E199
Paoli A, Rubini A, Volek JS, Grimaldi KA. Beyond weight loss: a review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets. Eur J Clin Nutr. 2013;67(8):789–96. https://doi.org/10.1038/ejcn.2013.116 .
doi: 10.1038/ejcn.2013.116
pubmed: 23801097
pmcid: 3826507
Ibrahim MM. Subcutaneous and visceral adipose tissue: structural and functional differences. Obes Rev. 2010;11(1):11–8. https://doi.org/10.1111/j.1467-789X.2009.00623.x .
doi: 10.1111/j.1467-789X.2009.00623.x
pubmed: 19656312
Aronica L, Rigdon J, Offringa LC, Stefanick ML, Gardner CD. Examining differences between overweight women and men in 12-month weight loss study comparing healthy low-carbohydrate vs. low-fat diets. Int J Obes. 2021;45(1):225–34. https://doi.org/10.1038/s41366-020-00708-y .
doi: 10.1038/s41366-020-00708-y
Christensen P, Meinert Larsen T, Westerterp-Plantenga M, et al. Men and women respond differently to rapid weight loss: Metabolic outcomes of a multi-centre intervention study after a low-energy diet in 2500 overweight, individuals with pre-diabetes (PREVIEW). Diabetes Obes Metab. 2018;20(12):2840–51. https://doi.org/10.1111/dom.13466 .
doi: 10.1111/dom.13466
pubmed: 30088336
pmcid: 6282840
Sumithran P, Purcell K, Kuyruk S, Proietto J, Prendergast LA. Combining biological and psychosocial baseline variables did not improve prediction of outcome of a very-low-energy diet in a clinic referral population. Clin Obes. 2018;8(1):30–8. https://doi.org/10.1111/cob.12229 .
doi: 10.1111/cob.12229
pubmed: 29119687
Guo X, Xu Y, He H, et al. Effects of a meal replacement on body composition and metabolic parameters among subjects with overweight or obesity. J Obes. 2018;2018:2837367. https://doi.org/10.1155/2018/2837367 .
doi: 10.1155/2018/2837367
pubmed: 30687550
pmcid: 6327254
Barrea L, Muscogiuri G, Aprano S, et al. Phase angle as an easy diagnostic tool for the nutritionist in the evaluation of inflammatory changes during the active stage of a very low-calorie ketogenic diet. Int J Obes (Lond). 2022;46(9):1591–7. https://doi.org/10.1038/s41366-022-01152-w .
doi: 10.1038/s41366-022-01152-w
pubmed: 35614205
Lang F, Busch GL, Ritter M, et al. Functional significance of cell volume regulatory mechanisms. Physiol Rev. 1998;78(1):247–306. https://doi.org/10.1152/physrev.1998.78.1.247 .
doi: 10.1152/physrev.1998.78.1.247
pubmed: 9457175
Chambers JM. Graphical methods for data analysis. 1983.
Jequier E, Constant F. Water as an essential nutrient: the physiological basis of hydration. Eur J Clin Nutr. 2010;64(2):115–23. https://doi.org/10.1038/ejcn.2009.111 .
doi: 10.1038/ejcn.2009.111
pubmed: 19724292
Popkin BM, D’Anci KE, Rosenberg IH. Water, hydration, and health. Nutr Rev. 2010;68(8):439–58. https://doi.org/10.1111/j.1753-4887.2010.00304.x .
doi: 10.1111/j.1753-4887.2010.00304.x
pubmed: 20646222
Wong LL, Verbalis JG. Systemic diseases associated with disorders of water homeostasis. Endocrinol Metab Clin North Am. 2002;31(1):121–40. https://doi.org/10.1016/s0889-8529(01)00007-x .
doi: 10.1016/s0889-8529(01)00007-x
pubmed: 12055984
Adler SM, Verbalis JG. Disorders of body water homeostasis in critical illness. Endocrinol Metab Clin North Am. 2006;35(4):873–94. https://doi.org/10.1016/j.ecl.2006.09.011 .
doi: 10.1016/j.ecl.2006.09.011
pubmed: 17127152
Chrousos GP, Papadopoulou-Marketou N, Bacopoulou F, Lucafo M, Gallotta A, Boschiero D. Photoplethysmography (PPG)-determined heart rate variability (HRV) and extracellular water (ECW) in the evaluation of chronic stress and inflammation. Hormones. 2022;21(3):383–90. https://doi.org/10.1007/s42000-021-00341-y .
doi: 10.1007/s42000-021-00341-y
pubmed: 35028916
Vicente-Martinez M, Martinez-Ramirez L, Munoz R, et al. Inflammation in patients on peritoneal dialysis is associated with increased extracellular fluid volume. Arch Med Res. 2004;35(3):220–4. https://doi.org/10.1016/j.arcmed.2004.01.003 .
doi: 10.1016/j.arcmed.2004.01.003
pubmed: 15163463
Woodrow G, Oldroyd B, Wright A, et al. Abnormalities of body composition in peritoneal dialysis patients. Perit Dial Int. 2004;24(2):169–75.
doi: 10.1177/089686080402400208
pubmed: 15119638
Plum J, Schoenicke G, Kleophas W, et al. Comparison of body fluid distribution between chronic haemodialysis and peritoneal dialysis patients as assessed by biophysical and biochemical methods. Nephrol Dial Transplant. 2001;16(12):2378–85. https://doi.org/10.1093/ndt/16.12.2378 .
doi: 10.1093/ndt/16.12.2378
pubmed: 11733630
Asghar RB, Green S, Engel B, Davies SJ. Relationship of demographic, dietary, and clinical factors to the hydration status of patients on peritoneal dialysis. Perit Dial Int. 2004;24(3):231–9.
doi: 10.1177/089686080402400305
pubmed: 15185771
Avila-Diaz M, Ventura MD, Valle D, et al. Inflammation and extracellular volume expansion are related to sodium and water removal in patients on peritoneal dialysis. Perit Dial Int. 2006;26(5):574–80.
doi: 10.1177/089686080602600510
pubmed: 16973513
Mendall MA, Patel P, Ballam L, Strachan D, Northfield TC. C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ. 1996;312(7038):1061–5. https://doi.org/10.1136/bmj.312.7038.1061 .
doi: 10.1136/bmj.312.7038.1061
pubmed: 8616412
pmcid: 2350910
Barrea L, Verde L, Vetrani C, et al. VLCKD: a real time safety study in obesity. J Transl Med. 2022;20(1):23. https://doi.org/10.1186/s12967-021-03221-6 .
doi: 10.1186/s12967-021-03221-6
pubmed: 34998415
pmcid: 8742928
Jialal I, Devaraj S. Inflammation and atherosclerosis: the value of the high-sensitivity C-reactive protein assay as a risk marker. Am J Clin Pathol. 2001;116(Suppl):S108-115. https://doi.org/10.1309/J63V-5LTH-WYFC-VDR5 .
doi: 10.1309/J63V-5LTH-WYFC-VDR5
pubmed: 11993695